Drugmakers warily eye the nutraceuticals market

08/30/2011 | PharmExec.com

Unlike the brand-name prescription drug market, the nutraceuticals market is expected to grow over the coming years, and some big drugmakers are tentatively testing the waters while others are steering clear. Drugmakers are nervous about running afoul of FDA regulations, brand-name dilution and low margins, analysts say. But the market may be an excellent opportunity for pharma to refill pipelines. "Given the pipeline gap, pharma can't afford to cede the nutraceuticals market to [consumer goods companies] like Nestlé, a company that is actively climbing over the fence into pharmaceuticals," writes industry expert Ben Comer.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA